已发表论文

纳米技术在脓毒症治疗中的进展、挑战与未来前景

 

Authors Liu Y, Liu J, Wang D, Xu L, Li Z, Bai X, Zhu H, Wang Y 

Received 21 July 2024

Accepted for publication 16 May 2025

Published 16 June 2025 Volume 2025:20 Pages 7685—7714

DOI https://doi.org/10.2147/IJN.S488026

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 4

Editor who approved publication: Prof. Dr. Dongwoo Khang

Yukun Liu,1 Jiafeng Liu,1 Dongfang Wang,2 Ligang Xu,2 Zhanfei Li,2 Xiangjun Bai,2 Hao Zhu,3 Yuchang Wang2 

1Department of Plastic and Cosmetic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People’s Republic of China; 2Trauma Center/Department of Emergency and Traumatic Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People’s Republic of China; 3Department of Orthopedics Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People’s Republic of China

Correspondence: Hao Zhu, Email zhuhao_92@hust.edu.cn Yuchang Wang, Email tjwangyuchang@163.com

Abstract: Sepsis is a life-threatening systemic inflammatory syndrome, typically triggered by infection, that can lead to multi-organ failure and high mortality rates. Traditional treatments for sepsis often have limited efficacy and significant side effects, necessitating the exploration of innovative therapeutic strategies. In recent years, the application of nanotechnology in sepsis therapy has garnered widespread attention due to its potential to modulate immune responses, reduce inflammation and oxidative stress, and eliminate bacterial toxins. This review aims to provide an overview of the latest advancements, challenges, and future prospects of nanotechnology in sepsis treatment. By analyzing recent developments in anti-inflammatory, immunomodulatory, antioxidant, and detoxification applications of nanotechnology, key findings and therapeutic potential are summarized, including the use of nanocarriers, biomimetic nanoparticles, and self-assembled nanomaterials. Furthermore, this review addresses the challenges in clinical translation, such as drug targeting, long-term safety, and biocompatibility. Future research will require large-scale clinical trials and interdisciplinary collaboration to validate the efficacy of nanotechnology in sepsis treatment and facilitate its integration into clinical practice. Overall, nanotechnology presents unprecedented opportunities for sepsis management, and this review seeks to offer insights into ongoing research while promoting further advancements in this field.

Keywords: sepsis, MODS, nanotechnology, nanomedicine delivery methods, nanoimmunotherapy